PUBLISHER: GlobalData | PRODUCT CODE: 1410841
PUBLISHER: GlobalData | PRODUCT CODE: 1410841
Arteriotomy Closure Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Arteriotomy Closure Devices market for the year 2020 and beyond. Arteriotomy Closure Devices are used to achieve hemostasis of an arterial puncture site. In order to perform minimally invasive cardiovascular diagnostic and interventional procedures, arterial access is created via a puncture in the femoral or radial artery. Arteriotomy Closure Devices are of 2 types: Passive Closure Devices and Active Closure Devices. Passive Closure Devices provide controlled compression of the artery. These include sealant and clamps/tamps, whereas active closure devices are used for the immediate closure of arterial access sites through the use of collagen plugs, sutures, or clips.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Arteriotomy Closure Devices market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Terumo Corp, Abbott Laboratories, Hellman and Friedman LLC, Teleflex Inc, Haemonetics Corp, Merit Medical Systems Inc, Marine Polymer Technologies Inc, Biolife LLC, Medtronic Plc, LeMaitre Vascular Inc, Advanced Vascular Dynamics, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable